131 related articles for article (PubMed ID: 9139622)
1. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results.
Bosch T
Artif Organs; 1996 Apr; 20(4):344-5. PubMed ID: 9139622
[TBL] [Abstract][Full Text] [Related]
2. LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.
Bosch T; Schmidt B; Kleophas W; Gillen C; Otto V; Passlick-Deetjen J; Gurland HJ
Artif Organs; 1997 Sep; 21(9):977-82. PubMed ID: 9288867
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center.
Bosch T; Lennertz A; Kordes B; Samtleben W
Ther Apher; 1999 Aug; 3(3):209-13. PubMed ID: 10427617
[TBL] [Abstract][Full Text] [Related]
4. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood.
Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W
Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759
[TBL] [Abstract][Full Text] [Related]
5. LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients.
Bosch T; Schmidt B; Kleophas W; Otto V; Samtleben W
Artif Organs; 1997 Oct; 21(10):1060-5. PubMed ID: 9335362
[TBL] [Abstract][Full Text] [Related]
6. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood.
Bosch T; Schmidt B; Blumenstein M; Gurland HJ
Artif Organs; 1993 Jul; 17(7):640-52. PubMed ID: 8338441
[TBL] [Abstract][Full Text] [Related]
7. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
8. Lipid apheresis: from a heroic treatment to routine clinical practice.
Bosch T
Artif Organs; 1996 May; 20(5):414-9. PubMed ID: 8725620
[TBL] [Abstract][Full Text] [Related]
9. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
10. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a).
Superko HR; Krauss RM
J Am Coll Cardiol; 2000 Feb; 35(2):321-6. PubMed ID: 10676676
[TBL] [Abstract][Full Text] [Related]
11. Pancytopenia with severe thrombocytopenia in a patient treated with twice-weekly LDL-apheresis by polyacrylate adsorption from whole blood.
Nowack R; Wiedemann G
J Clin Apher; 2010; 25(2):77-80. PubMed ID: 20101676
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe hyperlipidemia: six years' experience with low-density lipoprotein apheresis.
Bambauer R; Schiel R; Latza R; Klinkmann J
Artif Organs; 1996 Apr; 20(4):336-9. PubMed ID: 9139620
[TBL] [Abstract][Full Text] [Related]
13. Lipid apheresis techniques: current status in Germany.
Grützmacher P; Kleinert C
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):20-3. PubMed ID: 22911177
[TBL] [Abstract][Full Text] [Related]
14. Low density lipoprotein (LDL) apheresis is currently recognized as a reliable tool for removal of LDL cholesterol directly from blood in patients with severe hypercholesterolemia.
Agishi T
Artif Organs; 2000 Feb; 24(2):165-6. PubMed ID: 10718772
[No Abstract] [Full Text] [Related]
15. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
[TBL] [Abstract][Full Text] [Related]
16. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).
Waldmann E; Parhofer KG
Pathology; 2019 Feb; 51(2):227-232. PubMed ID: 30611543
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
[TBL] [Abstract][Full Text] [Related]
18. Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
Julius U; Parhofer KG; Heibges A; Kurz S; Klingel R; Geiss HC
J Clin Apher; 2007; 22(4):215-23. PubMed ID: 17455220
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal removal of lipids by dextran sulfate cellulose adsorption.
Olbricht CJ
Artif Organs; 1996 Apr; 20(4):332-5. PubMed ID: 9139619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
